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SUMMARY
In causing disease, pathogens outmaneuver
host defenses through a dedicated arsenal of
virulence determinants that specifically bind or
modify individual host molecules. This dedica-
tion limits the intruder to a defined range of
hosts. Newly emerging diseases mostly involve
existing pathogens whose arsenal has been al-
tered to allow them to infect previously inacces-
sible hosts. We have emulated this chance
occurrence by extending the host range acces-
sible to the human pathogen Listeriamonocyto-
genes by the intestinal route to include the
mouse. Analyzing the recognition complex of
the listerial invasion protein InlA and its human
receptor E-cadherin, we postulated and verified
amino acid substitutions in InlA to increase its
affinity for E-cadherin. Two single substitutions
increase binding affinity by four orders of mag-
nitude and extend binding specificity to include
formerly incompatiblemurineE-cadherin.By ra-
tionally adapting a single protein,we thus create
a versatile murine model of human listeriosis.
INTRODUCTION
The constant interaction of humans with countless micro-
organisms has led to the evolution of an intricate, multifac-
eted, and remarkably efficient immune system. Pathogens
have, however, coevolved, refining their arsenal of patho-
genicity factors to exploit loop holes in the host’s defenses
(Akira et al., 2006). This dedicated specialization of patho-
gens restricts their choice of alternative hosts and limits
the usefulness of animal models to study human patho-
gens in vivo. Molecular mechanisms defining host tropism
have been identified for a limited number of pathogens,
including the food-borne human pathogen Listeria mono-
cytogenes (Hamon et al., 2006). These include two listerial
invasion proteins, internalin (InlA) and InlB, that promote
uptake of bacteria into distinct sets of nonphagocytotic
cells (Cossart et al., 2003).
InlA promotes listerial uptake into intestinal epithelial
cells (Gaillard et al., 1991) by targeting the N-terminal do-
main of human E-cadherin (hEC1) (Mengaud et al., 1996),
the dominant adhesion molecule of adherens junctions
(D’Souza-Schorey, 2005). InlA similarly recognizes E-cad-
herin from guinea pig and rabbit but fails to bind the corre-
sponding domain of murine E-cadherin (mEC1), despite
a sequence identity of 90% to hEC1 (Lecuit et al., 1999)
and a pronounced structural similarity (Schubert et al.,
2002). Among other targets, the second listerial invasion
protein InlB recognizes the HGF or Met receptor (Shen
et al., 2000) inducing uptake into a wide range of mamma-
lian cells including hepatocytes and endothelial cells. InlB
recognizes both murine and human Met receptor but not
that of the guinea pig and rabbit (Khelef et al., 2006). The
lack of a small-animal model to study the interplay of
InlA and InlB in human listeriosis in vivo was first ad-
dressed by the generation of a transgenic mouse produc-
ing human alongside murine E-cadherin in its enterocytes
(Lecuit et al., 2001), thereby allowing the role of InlA and of
other virulence factors to be characterized in orally in-
fectedmice (Sabet et al., 2005; Khelef et al., 2006; Boneca
et al., 2007).
Animal models for other pathogens have similarly been
created by the genetic humanization of mice (Lecuit and
Cossart, 2002). However, because pathogens typically
abuse host molecules of complex biological function, hu-
manizing such molecules may incur unexpected second-
ary effects. Humanized mouse lines, furthermore, need to
be crossed with existing knockout strains (Yap and Sher,
2002), thereby adding another level of complexity.
In nature, pathogens occasionally switch their host
specificity through spontaneous changes in their molecu-
lar arsenal (Gamblin et al., 2004), causing in high mortality
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rates in the naive host population (Weiss, 2003). Zoonotic
pathogens eliciting recent pandemics in the global human
population (Lewis, 2006) include HIV (Heeney et al., 2006)
and SARS (Li et al., 2005), whereas influenza A subtype
H5N1may be poised to do the same (Stevens et al., 2006).
We imitate this natural route of pathogen evolution by
extending the host spectrum of Listeria monocytogenes.
Our approach is based on the rational structure-based
re-engineering of InlA such that modified InlA is able to
recognize the previously incompatible receptor mEC1.
By adapting the bacterium to the mouse (‘‘murinization’’)
rather than humanizing the mouse, we introduce the
human route of infection in mice and hence provide
a versatile animal model to investigate listeriosis in vivo.
RESULTS
Structure-Based Virulence-Factor Design
Our working hypothesis was that the weak binding affinity
of InlA for hEC1 is due to imperfect surface complemen-
tarity and hence numerous bridging water molecules be-
tween the two proteins (Schubert et al., 2002). To increase
binding affinity, we proposed individual amino acid substi-
tutions in InlA (Figure 1A) to create additional, stabilizing
contacts to hEC1, thus improving complementarity and
binding affinity.
Although Ser192 of InlA (Ser192InlA) faces hEC1 in the
complex InlA/hEC1, its side chain is too short for a direct
hydrogen bond to hEC1. Replacing it by asparagine could
allowsuchadirect interaction. Solving the crystal structure
of InlAS192N/hEC1 confirms that engineered Asn192InlA
creates a direct hydrogenbond to themain-chain carbonyl
of Phe17hEC1 (Figure 1B). Correspondingly, isothermal
titration calorimetry (ITC) indicates the dissociation con-
stant (KD) of InlA
S192N/hEC1 to be 200 ± 50 nM (Figure 2),
a 40-fold increase in binding affinity relative to InlAWT/hEC1
(KD = 8 ± 4 mM).
To improve the unfavorable interaction of bulky
Tyr369InlA to hEC1, we chose to replace it by the small
hydrophilic amino acid serine. The crystal structure of
the double variant InlAS192N-Y369S (henceforth denoted
InlAm) in complex with hEC1 confirms that the interaction
of Tyr369InlA has been replaced by a water-mediated
hydrogen bond from Ser369InlA to Asn27hEC1 (Figure 1C).
The binding affinity of InlAm for hEC1 is found to be KD =
1.2 ± 0.3 nM by ITC. The substitution Y369SInlA thus
increases binding affinity by a factor of 170 (Figure 2),
whereas both substitutions together increase affinity
6700-fold compared to InlAWT/hEC1. Although separated
by 34 A˚, the substitutions convert a weak interaction to
a tight recognition. Note that a mere eight nonhydrogen
atoms within the recognition interface of InlA and hEC1
have been altered.
Figure 1. Re-engineered Variants of Internalin (InlA) in Complex with the N-Terminal Domain of Human E-Cadherin
(A) Superposition of InlA/hEC1 (violet) and InlAS192N-Y369S/hEC1 (gray).
(B) Critical residues near mutation site S192NInlA are shown as ball and stick. Asn192InlA adds a direct H bond to the carbonyl oxygen of Phe17hEC1.
(C) The mutation Y369SInlA introduces a water-bridged interaction to Asn27hEC1.
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Effect of Improved Affinity in Human Cells
To analyze the biological effects of improved affinity of
InlAm on the adhesion to and invasion of human epithelial
cells in vitro, we modified wild-type Listeria monocyto-
genes EGD (Lmo-EGD) by exclusively replacing the gene
inlA by inlAS192N-Y369S to produce the mutant strain
Lmo-InlAm. Our strategy of minimal intervention circum-
vents InlA and InlB expression-level changes caused by
disrupting the bicistronically transcribed inlAB locus (Ling-
nau et al., 1995). Both listerial invasion proteins are thus
expressed at native levels, ensuring that valid biological
conclusions may be drawn from the infection process
(Figure S1 in the Supplemental Data available online).
Binding of InlA to human E-cadherin induces listerial up-
take into human epithelial cells by the zipper mechanism
(Cossart and Sansonetti, 2004), requiring localized rear-
rangements of the cytoskeleton as well as a physically
tight interaction between bacterium and eukaryotic cell
membrane. To establish whether improved affinity of InlAm
for its receptor results in stronger adhesion of Lmo-InlAm,
we analyzed its adhesion to the E-cadherin expressing
human epithelial cell line Caco2. We observe a 2-fold in-
crease in the adhesion efficiency of Lmo-InlAm compared
to wild-type bacteria (Figure 3A).
We investigated the link between improved adhe-
sion of Lmo-InlAm and bacterial uptake by using
Figure 2. Re-engineering the Interaction
of InlA and E-Cadherin
Colored boxes represent protein complexes
and their dissociation constants (KD). Shades
of violet to cyan indicate complexes involving
human E-cadherin (hEC1), whereas shades of
yellow and white complexes indicate com-
plexes involving murine E-cadherin (mEC1).
Two substitutions in InlA generate InlAS192N
and InlAS192N-Y369S (InlAm). Binding affinity for
hEC1 increases 40- and 170-fold (together
6700-fold). The eleven substitutions separating
hEC1 and mEC1 reduce binding affinity of
InlAm 8300-fold. Coincidentally, binding affini-
ties of InlA/hEC1 (dark violet) and InlAm/mEC1
(yellow) are essentially identical. The affinity of
InlAm and InIAWT for mEC1E16P is significantly
lower than for hEC1. Doubly substituted
mEC1E16P-Q64E is recognized with similar affin-
ity as hEC1, indicating improved humanization
of mEC1 (white boxes). The asterisks indicate
nine substitutions that separate hEC1 from
mEC1E16P-Q64E.
Figure 3. Adhesion and Intracellular
Growth of Lmo-EGD and Lmo-InlAm
(A) Adhesion assay. Confluent layers of Caco2
cells were infected with Lmo-EGD, Lmo-DInlA,
or Lmo-InlAm for 30min. Cells were washed ex-
tensively, and lysates were plated onto BHI
agar plates.
(B and C) Intracellular growth curve of Lmo-
EGD and Lmo-InlAm in Caco2 cells. Extracellu-
lar bacteria were killed after 1 hr by gentamicin.
We quantified intracellular bacteria after 1–4 hr
by plating cell lysates onto BHI agar plates. (B)
shows observed cfu-values. (C) shows that the
mean bacterial doubling time is 50 ± 4min (gra-
dient of the linear log cfu plotted against time).
(D) Intracellular growth curve of Lmo-EGD and
Lmo-InlAm in themacrophage-like cell line J774
where uptake is InlA independent. Cells were in-
fected for 30min, and intracellular bacteriawere
quantified after 1–4 hr. All observed cfu values
were corrected for differences in the starting
inoculum. Data show one representative of
three independently performed experiments.
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Gentamicin-protection-invasion assays (Elsinghorst, 1994).
We observe a doubling in the number of internalized
bacteria when expressing InlAm compared to InlAWT
(Figure 3B). Increased invasion thus appears to be pre-
dominantly caused by improved adhesion of Lmo-InlAm
to Caco2 over Lmo-EGD.
After phagocytosis, bacteria need to escape from the
phagosome to avoid lysosomal degradation. To rule out
that factors after uptake affect the observed increase in
intracellular bacteria, we analyzed intracellular growth
rates of Lmo-EGD and Lmo-InlAm. A plot of colony-form-
ing units (cfu) against time (Figure 3B) indicates a similar
exponential increase for both Lmo-EGD and Lmo-InlAm.
A logarithmic plot (Figure 3C) reveals the replication time
of both strains to be 50 ± 4min (gradient). The re-engineer-
ing of InlA therefore predominantly affects the process of
listerial adhesion, whereas uptake, phagosomal escape,
intracellular replication rates, and cell-to-cell spread
appear unaltered.
As a control, we compared intracellular growth curves
of both strains in the professionally phagocytic, macro-
phage-like cell line J774, where uptake is InlA indepen-
dent (Dramsi et al., 1997). We observe indistinguishable
invasion efficiencies and intracellular replication times of
46 ± 3 min for both strains (Figure 3D). InlA-independent
pathophysiological characteristics of Lmo-EGD thus
remain unaltered in Lmo-InlAm.
Modifying Binding Specificity
Although E-cadherin and in particular the N-terminal
domain EC1 is highly conserved among mammals, the
differences in amino acid sequence vary sufficiently to
disallow binding of InlA tomurine EC1 (mEC1). As a conse-
quence, E-cadherin-based invasion of murine epithelial
cells does not occur (Lecuit et al., 1999).
We find the dissociation constant of InlAm/mEC1 to be
KD = 10 ± 2 mM (Figure 2). Although weak, the binding af-
finity almost perfectly matches the KD = 8 ± 4 mM for
InlAWT/hEC1 (Schubert et al., 2002). The high-resolution
crystal structure of InlAm/mEC1 (Figures 4B–4D and Table
S1) indicates that the relative orientations of mEC1 and
InlAm are unchanged from InlA/hEC1 (r.m.s.d. for main-
chain atoms 0.7 A˚). The hydrogen bonds introduced to
strengthen the interaction of InlA/hEC1 (see above) are re-
tained in InlAm/mEC1, thereby giving rise to the altered
specificity of InlA.
Differences between InlA/hEC1 and InlAm/mEC1 most
noticeably involve residues 16 of hEC1 and mEC1 and
their immediate neighborhood. Pro16hEC1 adopts a
strained cis conformation, optimally positioning its side
chain within a hydrophobic binding pocket of InlA (Fig-
ure 4C). Glu16mEC1 of the engineered complex, by con-
trast, adopts a relaxed trans conformation, permitting
the backbone to move aside to accommodate the longer
glutamate side chain. Unexpectedly, the carboxy group
of Glu16mEC1 occupies the same hydrophobic pocket of
InlA as Pro16hEC1 in InlA/hEC1 (Figure 4C). Glu16mEC1
additionally induces a local rearrangement that involves
Lys19mEC1 and that repositions the latter away from
a salt bridge to Glu255InlA observed in InlA/hEC1 (Schu-
bert et al., 2002). The low binding affinity of InlA for
mEC1 is thus not only due to the disparate physical prop-
erties of glutamate and proline but also due to local adjust-
ments within EC1 (Figure 4D).
A Second Determinant of Binding Affinity
The substitution of Pro16hEC1 by Glu16mEC1 clearly domi-
nates the host tropism of L. monocytogenes (Lecuit et al.,
1999). Genetically replacing Glu16mEC1 by proline in mice
has been proposed as a route to create a new animal
model, rendering all E-cadherin expressing cells suscep-
tible to InlA-mediated entry (Lecuit, 2005). Analyzing the
affinity of InlA for mEC1E16P biophysically, we find the in-
teraction to be exceedingly weak (KD > 40 mM), preventing
the binding affinity from being quantified unambiguously.
We estimate the binding affinity as follows: InlAm binds
mEC1E16P with a KD = 14 ± 4 nM (Figure 2) and thus con-
firms the dominant effect (factor of 700) of the Glu16Pro
substitution. The ten remaining substitutions in mEC1
(Figure 4A) contribute a factor of 12 (Figure 2). Provided
the changes are largely additive, the KD of InlA/mEC1
E16P
would be 12 3 KD = 8 mM (InlA/hEC1) or 96 mM
(Figure 2). In InlA-coated latex beads, this low binding
affinity could be offset by a high density of InlA molecules
leading to recognition of mEC1P16E-expressing cells
(Lecuit et al., 1999). On the surface of Listeria, physical
and physiological constraints would limit the density of
InlA, preventing efficient adhesion and hence uptake of
Lmo-EGD.
The crystal structure of InlAm/mEC1 reveals that a sec-
ond substitution in mEC1 is involved in InlAm recognition.
In InlA/hEC1, Glu64hEC1 forms a salt bridge to Arg85InlA
(Figures 4A and 4B). In mEC1, this glutamate is replaced
by glutamine, substituting the salt bridge by a hydrogen
bond to Arg85InlA. Reverting these two substitutions in
mEC1 produces mEC1P16E-Q64E with an affinity of KD =
4 ± 2 nM for re-engineered InlAm (Figure 2) or KD = 11 ±
4 mM for InlAWT—similar to that of InlA/hEC1 (KD = 8mM).
A transgenic mouse bearing both the substitutions Glu16-
Pro and Gln64Glu in murine E-cadherin could therefore
represent a system more closely resembling the human
situation than the singly substituted protein.
Altered Host Tropism In Vivo
To establish whether increased binding affinity of InlAm for
murine E-cadherin will allow infection of the murine intes-
tine comparable to that of humans, we infected C57BL/6J
mice intragastrically with both Lmo-EGD and Lmo-InlAm.
Challenging mice with 5 3 107 to 5 3 1010 Lmo-InlAm
results in dose-dependent mortality rates (Figure 5A).
The median lethal dose is inferred to be53 107. By con-
trast, the highest achievable inoculum of 5 3 1010 of
Lmo-EGD is lethal only for 20% of infected mice
(Figure 5A, dashed line). Lmo-InlAm is thus at least three
orders of magnitude more virulent in mice than wild-
type Lmo-EGD.
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To establish the route of infection of Lmo-InlAm in mice,
we analyzed the load of Lmo-InlAm and Lmo-EGD in af-
fected organs, after intragastric challenge with 1 3 1010
bacteria (Figure 5 and Figure S2). In stomach and intestine,
loads of Lmo-InlAm and Lmo-EGD (Figures 5B and 5C) are
largely comparable until day 2 post infection (p.i.). There-
after, Lmo-InlAm loads increase strongly (Figures 5B and
5C), whereas loads of Lmo-EGD remain constant.
In mesenteric lymph nodes, the spleen, and the liver,
bacterial loads of both strains increase until day 2 p.i. (Fig-
ures 5D–5F). Lmo-EGD counts then stabilize inmesenteric
lymph nodes, the spleen, and the liver (infection con-
trolled). In Lmo-InlAm-infectedmice, by contrast, stabiliza-
tion of bacterial numbers is not observed. Instead, bacte-
rial loads increase exponentially in the spleen and liver
until day 4 p.i. (solid lines, Figures 5E and 5F), resulting
in 1.000-fold greater bacterial numbers in the spleen and
liver in Lmo-InlAm than in Lmo-EGD on day 4 p.i. Bacterial
counts in mesenteric lymph nodes diverge after day 2 p.i.,
but loads of Lmo-InlAm increase more slowly than in the
liver and spleen.
To compare bacterial-growth kinetics at a lower infec-
tion dose, we challenged mice intragastrically with 53 107
of Lmo-EGDandLmo-InlAm (FigureS3). Again,weobserve
enhanced virulence for Lmo-InlAm relative to Lmo-EGD.
Although the effect in terms of bacterial numbers is not
as pronounced as for the higher dose, slower kinetics of
bacterial dissemination allow later time points to be inves-
tigated. In the stomach and small intestine, differences in
bacterial loads become significant by day 5 p.i. In the
Figure 4. Comparison of InlA/hEC1 and InlAm/mEC1 Complexes
(A) Sequence alignment of the N-terminal, extracellular domains (EC1) of human (hEC1, violet), and murine (mEC1, yellow) E-cadherin. Sequence
differences involving charged residues are marked by red and blue boxes, and all others were marked by green boxes.
(B) Superposition of both protein complexes. LRRs are numbered. Critical residues are shown as ball and stick, and solvent-exposed substitutions
are shown as spheres (colors are as shown in [A]).
(C) Hydrophobic Pro16hEC1 (violet) is accommodated in a hydrophobic pocket of InlA. The carboxylate of Glu16mEC1 (yellow), well defined in the
2FO-FC difference electron density (green, contoured at 1s), occupies the same pocket.
(D) Lys19hEC1 forms a favorable salt bridge to InlA. TransGlu16mEC1 repositions Lys19mEC1, trapping its side-chain through an intramolecular H-bond
(arrow).
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spleen, liver, and mesenteric lymph nodes, Lmo-InlAm
loads are consistently higher than those of Lmo-EGD.
Histological Analysis of InlA-Dependent
Infection Mechanisms
Histological and immunohistochemical studies of Peyer’s
patches of infected mice indicate that both Lmo-EGD and
Lmo-InlAm remain restricted to the dome and germinal
centers, where they induce neutrophil infiltration and
necrosis (Figures S4A–S4D) with gradually increasing se-
verity along the small-intestinal axis. Colonization is, how-
ever, essentially indistinguishable until day 4 p.i. Whereas
the Lmo-EGD infection subsides after day 4 p.i., no such
remission is observed for Lmo-InlAm.
Immunohistochemical analyses of the intestinal mu-
cosa clearly demonstrate that Lmo-EGD do not invade
epithelial tissue (Figure 6). Instead, bacteria are exclu-
sively observed in the lumen or occasionally adhere to
the surface of individual villi (Figures 6B, 6F, and 6J) as
late as day 4 p.i. (Figure 6N). Similarly, the intestinal tissue
is fully intact without any signs of inflammation until day
3 p.i. (Figures 6A and 6E). Transient inflammatory re-
sponse with enhanced mucus secretion and mild, local
erosion of epithelium is present at day 4 p.i. (Figure 6I).
The inflammation, however, subsides by day 5 p.i.
(Figure 6M).
In Lmo-InlAm-infected mice, colonization of epithelia at
villous tips are observed 24 hr p.i. in the ileum (Figure 6D),
rapidly spreading to extended areas of the epithelium and
accumulating within the lamina propria (subepithelial
tissue) (Figures 6H, 6L, and 6P). On day 4 p.i., high bacte-
rial loads cause erosion of the epithelium and fusion of villi
(Figures 6K and 6O). Lesions are more pronounced in the
ileum than in the duodenum and jejunum.
Role of InlA in Systemic Spread
To analyze the role of InlAm in systemic infections of inter-
nal organs independently of intestinal uptake, we inocu-
lated mice intravenously (i.v.) with both low (5 3 103) or
high (2.4 3 104) doses of Lmo-EGD or Lmo-InlAm. In con-
trast to the oral route of infection, the survival rates for
both strains are found to be indistinguishable for both
bacterial doses (Figures 7A and 7B). Similarly, bacterial
loads in mesenteric lymph nodes, the spleen, and the liver
at different time points after i.v. inoculation demonstrate
Figure 5. Survival of Mice Intragastrically Infectedwith Lmo-EGD and Lmo-InlAm and Associated Bacterial Organ Loads over Time
Survival curves (A) and organ loads (B–F) of female C57BL/6J mice inoculated intragastrically with Lmo-EGD (dashed curve,B) or Lmo-InlAm (solid
curves,C). (A) shows that Lmo-InlAm exhibit more than 1000-fold higher virulence than wild-type Lmo-EGD (inocula as indicated, n = 10 for each
bacterial strain and experiment). (B–F) shows that 13 1010 bacteria of either strain were administered intragastrically to analyze kinetics of bacterial
growth (n = 6 for 24 h p.i. and n = 12 for all others). Organ loads were ascertained at five time points in the stomach (B), small intestine (C), mesenteric
lymph nodes (D), spleen (E), and liver (F). All data are from two independent experiments. The bar represents the median for each time point and ge-
notype; 95%confidence intervals are indicated. Statistical significance byMann-Whitney U nonparametric test: *p < 0.05, **p < 0.01, and ***p < 0.001.
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comparable virulence of Lmo-EGD and Lmo-InlAm (Fig-
ures 7C–7E).
Blood-Placental Barrier
Lmo-EGD remains problematic to humans inter alia be-
cause of its ability to cross the blood-placental barrier,
thereby resulting in sepsis or miscarriage. Ex vivo experi-
ments have shown that InlA-mediated entry into human
placental trophoblasts is important in placental infection
(Lecuit et al., 2004). Studies of Lmo-EGD-infected preg-
nant BALB/c mice (functional InlB, nonfunctional InlA)
(Le Monnier et al., 2007) and guinea pigs (functional InlA
and nonfunctional InlB) (Bakardjiev et al., 2004) indicate
that InlA and InlB individually are insufficient at inducing
vertical transmission in vivo. They, however, confirm tro-
phoblasts to be the primary target of Lmo-EGD. To ascer-
tain whether the combination of functional InlA and InlB fa-
cilitates vertical transmission, we analyzed the ability of
Lmo-InlAm to breach the murine blood-placental barrier.
Pregnant BALB/c mice were infected orally with 5 3 109
cfu of Lmo-EGD or Lmo-InlAm at embryonic day (E13.5)
or E14.5 of gestation. We find bacterial loads of fetal-pla-
cental units at day 2, 3, and 4 p.i. to be indistinguishable
(Figure S5). Histopathological analysis of placentas and
embryos confirm that lesions and inflammatory responses
are similar in mice infected with either strain (Figure S6).
Equivalent bacterial loads were also observed in fetal-pla-
cental units in female mice challenged with 5 3 104 cfu
Figure 6. Comparing the Spread of Lmo-EGD and Lmo-InlAm in the Small Intestine
Histology and immunohistochemical detection of Listeria in the distal part of the small intestine of C57BL/6J mice 24, 48, 96, and 120 hr after intra-
gastric inoculation with 1.53 1010 Lmo-EGD or Lmo-InlAm. The intestinal epitheliumwas analyzed by H&E staining or anti-Listeria immunohistochem-
istry. In Lmo-EGD-infected mice, no lesions and inflammatory responses are seen either (A) 24 or (E) 48 hr p.i. (I) shows that 96 hr p.i., moderate in-
flammation is visible with mild apical epithelial cell necrosis (horizontal arrows) and increased secretion of mucus (star). (M) demonstrates that 120 hr
p.i., the intestinal epithelium is fully regenerated. This correlates with anti-Listeria staining, where Lmo-EGD are located in the intestinal lumen, occa-
sionally associated with villi surfaces, without detectable invasion (B, F, J, and N). (C) and (D) show that 24 hr p.i., Lmo-InlAm-infectedmice reveal mild
erosion of epithelial cells exclusively seen at tips of the villi (horizontal arrows). (G) and (K) show that 48 and 96 hr p.i., widespread necrosis, loss of
villous epithelial cells (horizontal arrows), andmassive secretion ofmucus (indicated by stars) are clearly visible. Neutrophils and lymphocytes (vertical
arrows) infiltrate the villi. (H) and (L) show that these observations coincide with extensive colonization of the epithelium and deeper tissues (lamina
propria) of villi by Lmo-InlAm. (O) shows that 120 hr p.i., necrotic enterocytes are shed into the intestinal lumen (horizontal arrows). Overproduction of
mucus (stars) and distortion of villous structures are also apparent. (P) shows that this corresponds to extensive growth of Lmo-InlAm in the epithelium
and lamina propria. The scale bar (for all) represents 50 mm.
Cell 129, 891–902, June 1, 2007 ª2007 Elsevier Inc. 897
Lmo-InlAm and Lmo-EGD intravenously at day E14.5 (data
not shown). Crossing of the blood-placental barrier is thus
not InlA dependent in BALB/c mice.
DISCUSSION
Rationally Redesigning the InlA/hEC1 Complex
By usingminimal, structure-derivedmodifications of a sin-
gle pathogenicity factor, we have rationally redesigned the
interface of InlA/hEC1 to increase its binding affinity and, in
the process, modify the binding specificity of InlA to in-
clude murine E-cadherin. Incorporating these modifica-
tions into the original bacterium, we create a new listerial
strain that mimics the uptake of wild-type Lmo-EGD in
the human intestine in the mouse instead. Our approach
circumvents the limitations of existing models of listeriosis
in that both early and late responses are accessible and by
uniquely providing a system inwhich both InlA and InlB are
fully functional and expressed atwild-type levels. Because
intestinal uptake depends only on murine E-cadherin, all
mouse strains may be analyzed with Lmo-InlAm. It should,
furthermore, allow both host responses to food-borne
pathogens crossing the intestinal barrier and the role of in-
dividual listerial factors during infection to be analyzed in
an in vivo setting. To our knowledge, this is the first time
that a virulence factor hasbeen rationallymodified,without
relying on known mutations from related strains, or that
a novel strain of a pathogen has been created with an
extended host range.
Implications of InlAm affinity for EC1
To induce uptake into epithelial cells by the zipper-mech-
anism, L. monocytogenes must adhere tightly to the
eukaryotic-cell membrane. Accordingly, tighter adhesion
of Lmo-InlAm to Caco2 cells increases the efficiency of
uptake compared to wild-type Lmo-EGD. Surprisingly,
Figure 7. Survival Rates and Bacterial Organ Loads of Intravenously Infected Mice
Survival curves (A and B) and organ loads (C–E) of female C57BL/6J mice infected intravenously with either Lmo-EGD (dashed curves,B) or Lmo-
InlAm (solid curves,C). (A) and (B) show that the Lmo-InlAm strain exhibits no significantly higher virulence compared to wild-type Lmo-EGD strain at
low (5.03 103 cfu; [A]) and high (2.43 104 cfu; [B]) infection doses (n = 10). (C) and (D) show that both strains were inoculated i.v. with 93 103 bacteria
for analyzing entry of bacteria in deeper tissues without crossing the intestinal barrier. Organ loads (n = 6) were analyzed at three different time points
in the spleen (C), liver (D), and mesenteric lymph nodes (E). No appreciable enhanced virulence of the mutated strain Lmo-InlAm could be detected.
Note, however, that a statistically insignificant trend to higher virulence of Lmo-InlAm is detectable in survival experiments, as well as in organ counts
at days 3 and 6 p.i. Statistic evaluation is as shown in Figure 5.
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however, the 6700-fold increased binding affinity merely
causes a doubling in adhesion (Figure 3A). Because low
binding affinity may be counteracted by high protein con-
centration, the efficient adhesion of Lmo-EGD to Caco2
cells is probably due to the high amount of E-cadherin
on these cells.
In the intestinal epithelium, the amount of E-cadherin
accessible to L. monocytogenes apically is limited be-
cause of its basolateral localization. The exception being
multicellular junctions in epithelial monolayers where
E-cadherin is transiently exposed (Pentecost et al., 2006).
The low abundance of such junctions and the low affinity
of InlA for its receptor E-cadherin would severely limit up-
take of L. monocytogenes in vivo. By increase of binding
affinity, the available E-cadherin could be utilized more
efficiently, thus allowing a higher proportion of Lmo-InlAm
to invade the intestinal epithelium. Although pathogenicity
would be increased, higher rates of uptake of InlAm may
prove to be advantageous therapeutically as in oral vacci-
nation (Guimaraes et al., 2005), bacterial gene therapy
(Dietrich et al., 1998), or drug delivery (Sleator and Hill,
2006). Because regulation of E-cadherin is, intimately
linked to cell transformation and to the development of
cancer (Wheelock and Johnson, 2003), InlAmmay, further,
prove to be useful in the study of E-cadherin-mediated
signal transduction.
InlA-Dependent and -Independent Routes
of Listerial Infection
In mice, Lmo-EGD primarily target the Peyer’s patches
(Marco et al., 1997). Specialized, epithelial-like M cells
(Clark and Hirst, 2002) covering these centers of mucosal
immunity actively transport antigens and viable bacteria
from the intestinal lumen to the underlying immune cells
(Kraehenbuhl and Neutra, 2000). Food-borne pathogens
such as Salmonella or Shigella exploit this indiscriminate
uptake by reinvading M cells from the basolateral side,
spreading to cells of the adjoining epithelium (Cossart
and Sansonetti, 2004). E-cadherin on the basolateral
side of M cells potentially allows Lmo-EGD to employ
a similar strategy in humans. Our analyses, however, indi-
cate that colonization of M cells and Peyer’s patches by
Lmo-InlAm in mice is indistinguishable from that of Lmo-
EGD. Reinfection of M cells is thus not part of the listerial
invasion strategy. After their entry through Peyer’s
patches, both Lmo-EGD and Lmo-InlAm are probably
phagocytosed by macrophages independently of InlA
and InlB. The macrophages then traffic to mesenteric
lymph nodes and enter the blood stream as early as 12
hr p.i., thereby allowing bacteria to rapidly reach deeper
tissues. Additionally, listerial dissemination to the spleen
presumably involve CD8a+ dendritic cells, again indepen-
dent of InlA/B (Neuenhahn et al., 2006).
During this InlA-independent stage of listerial infection,
Lmo-EGD does not colonize the intestinal epithelium.
Mild immune responses in intestinal tissue in Lmo-EGD-
infected mice after day 3 p.i. are possibly caused by im-
mune cells activated in Peyer’s patches migrating into
the intestinal tissues (Mowat, 2003). Uptake of Lmo-EGD
into subepithelial tissue is not triggered, thus allowing
rapid remission.
Apart from Peyer’s patches (InlA independent), Lmo-
InlAm additionally infects the intestinal epithelium (InlA
dependent)—immunohistochemically observed 24 hr p.i.
(Figure 6D). During the next 2 days, Lmo-InlAm progres-
sively infects subepithelial connective tissue documented
by a steady increase in bacterial numbers in the intestine
(Figure 5C). By day 3 p.i., large numbers of bacteria colo-
nize the intestinal epithelial and subepithelial tissues (Fig-
ures 5C and 6L), thus opening a second, dominant route
of listerial dissemination. Compared to the InlA-indepen-
dent route, bacteria now access draining lymph nodes
and blood, directly leading to a dramatic increase in bac-
terial numbers in the liver and spleen (Figure 5F). The heavy
inflammation of the intestine additionally sequesters
immune resources and weakens the host.
Increasing bacterial numbers in mesenteric lymph no-
des and intestine until day 3 p.i. were also observed with
a transgenic mouse model, although the effect is not as
pronounced and subsides by day 5 p.i. (Lecuit et al., 2001).
The courses of infection after intravenous inoculation
are, perhaps surprisingly, indistinguishable for the two
listerial strains, implying that InlA is not essential for the
later stages of listerial infections. Transport of Listeria by
immune cells may bemore important for systemic spread-
ing than previously anticipated (Neuenhahn et al., 2006). A
tendency of slightly higher virulence of Lmo-InlAm indi-
cates that InlAmay nevertheless impart a slight advantage
during this stage of the infection as well. Overall, InlA is
crucial for establishing the infection of the intestinal epi-
thelium. InlB and potentially other virulence factors then
take over, leading to spread and systemic infection
(Hamon et al., 2006).
L. monocytogenes Infection in Pregnant Mice
Pregnancy in humans increases susceptibility toward
L. monocytogenes (Vazquez-Boland et al., 2001), and InlA
is reportedly crucial in crossing the blood-placental barrier
(Lecuit et al., 2004). Both pregnant mice (LeMonnier et al.,
2006; Le Monnier et al., 2007) and guinea pigs (Bakardjiev
et al., 2005) have been used to investigate this link. The
usefulness of these models is, however, limited by the re-
spective host specificities of InlA and InlB (see above).
Lmo-InlAm overcomes these limitations by providing ac-
tive InlA and InlB for themurine system. Infecting pregnant
mice orally with Lmo-InlAm mimics the human course of
infection and vertical transmission. We, however, do not
observe a significant difference between Lmo-EGD and
Lmo-InlAm both by intravenous and oral infection of
pregnant mice. This would indicate that the natural route
of placental infection in mice is not dependent on either
functional InlA or InlB. The uniquely invasive form of
trophoblast-cell-mediated hemochorial placentation in
humans (Moffett and Loke, 2006) could imply distinct sus-
ceptibilities for listerial infections. Alternatively, vertical
transmission may occur by the ‘‘Trojan horse’’ strategy
Cell 129, 891–902, June 1, 2007 ª2007 Elsevier Inc. 899
via infected monocytes or macrophages as discussed for
the blood-brain barrier (Drevets, 1999; Bakardjiev et al.,
2005). In this case, InlA-mediated entry would play a sub-
ordinate role and would only be detectable in vitro or
ex vivo where the ‘‘Trojan horse’’ mechanism is absent.
EXPERIMENTAL PROCEDURES
Protein Expression, Purification, and Crystallization
For structural and biophysical studies, functional fragments of InlA
(residues 36–496) and E-cadherin (EC1, residues 1–105), were used.
Murine EC1 (mEC1) was cloned from a cDNA library (German Re-
source Centre for Genome Research, clone ID IMAGp998A095392Q1)
into the pGEX-6P-1 expression vector as previously described for
hEC1 (Schubert et al., 2002). Site-directed mutations were introduced
by QuikChange Mutagenesis (Stratagene). Proteins were expressed
and purified as described (Schubert et al., 2002). Crystals were grown
by vapor diffusion with 5 mg/ml of protein and a stoichiometric ratio of
1:1. The reservoir solution for InlA-variant/hEC1 crystals was 20%–
25% PEG4000, 100 mM MES/Tris buffer (pH 7.0–7.5), 100 mM Na
acetate, and 20–100 mM CaCl2; for InlA
S192N-Y369S/mEC1, the reser-
voir solution was 20% PEG6000, 0.1 M Na citrate (pH 5.2), and
0.5 M LiCl, whereas 18% PEG400 (v/v) was added for cryoprotection.
Structure Determination
Data were collected at BL1, Protein Structure Factory, BESSY (l =
0.95A˚), and BW6, MPG (InlAS192N/hEC1, l = 1.05A˚) with MARCCD
detectors (Marresearch). Data were processed with XDS (Kabsch,
1988) and CCP4 suites (CCP4 [Collaborative Computational Project
4], 1994). The structure was solved by molecular replacement with
EPMR (Kissinger et al., 1999). The structural model was built, analyzed,
and validated with COOT (Emsley and Cowtan, 2004) and refined with
REFMAC5 (Murshudov et al., 1997). Figures were prepared with
PYMOL (www.pymol.org).
Isothermal Titration Calorimetry
Thermodynamic data were obtained with a MCS ITC (MicroCal). All
samples were dialyzed against 50 mM HEPES (pH 7.5) and 20 mM
CaCl2, and 5–10 ml aliquots of InlA variants were injected into the ITC
cell containing 1.35 ml of mEC1 or hEC1 variants, respectively. After
correction for heat of dilution (DHdil) data were analyzed with the
‘‘single set of independent sites’’ model (Micro Cal Origin 2.9).
Construction of the Isogenic Mutant Stain
of Listeria monocytogenes
Full-length inlA was amplified from genomic DNA with the primers
50-AGGAGGGATCCATGGTCGGACCAACGAGCCAACCGTG-30 and
50-AGGAGGCGGCCGCTGCTTGATTGGCGTTGGCACGGTG-30 and
cloned into the vector pPL2 (Lauer et al., 2002) with BamHI and NotI.
We incorporated the desired mutations by excising a 1026 nucleotide
BclI-BsaI fragment from pPL2 and replacing this with an equivalent
fragment from a pGEX-6P-1 expression vector containing the muta-
tion. A fragment, composed of the 30-part of inlA and the 50-part of
inlB was amplified with primers 50-AGGAGGGATCCAACCGTGACGC
AGCCACTTAAGGC-30 and 50-AGGAGCAAGTCCTGCTAATGCTCTTA
AATCGC-30. Digesting thiswithBamHI andXbaI allowed its ligation into
the BamHI/NheI-digested pETM11-GFP-FUS vector. The mutated 50-
part of inlA from the pPL2-inlAS192N-Y369S was cloned into vector
pETM11-GFP-FUS-inlAB with restriction enzymes BamHI and AflII.
The resulting plasmid bears full-length, mutated inlA, whereas the 50
inlB fragment is fused to gfp. The inlAS192N-Y369S-inlB-gfp fragment
was excised from pETM11-GFP-FUS-inlAS192N-Y369S-inlB by digesting
withNotI, filling in by Klenow polymerase and dNTP (NEB), heat inacti-
vation, and cutting with BamHI. The fragment was cloned into the
pAUL-A shuttle vector (Chakraborty et al., 1992) cut with HindIII, filled
in with Klenow polymerase and dNTP’s, heat inactivated, and digested
with BamHI. This vector pAUL-A-inlA-inlBwas integrated (Chakraborty
et al., 1992) into the Listeria monocytogenes EGD-e inlA2 knockout
strain (Lingnau et al., 1995). Reversion via homologous recombination
was achieved as described (Lingnau et al., 1995). All steps were mon-
itored by PCR analysis. The resulting strain, Lmo-InlAm, carries the in-
tact inlAB locus including two point mutations within inlA. The correct
reversion was confirmed by PCR sequencing and immunoblotting
with monoclonal antibodies against InlA and InlB.
Invasion Assays
Uptake of wild-type Listeria monocytogenes EGD serotype 1/2a
(ATCC-number BAA-679) and Lmo-InlAm were analyzed with the
human colorectal epithelial cell line Caco2 (ATCC HTB-37) and the
murine macrophage-like cell line J774 (ATCC TIB-67). Caco2 cells
were cultured in minimal essential medium (MEM) with Earle’s salts
(Invitrogen), supplemented with 20% FCS (PAA Laboratories), 2 mM
glutamine, 1 mM sodium pyruvate, and 1% nonessential amino acids
at 37C/7% CO2. J774 cells were cultured in Dulbecco’s modified
Eagle’s medium (DMEM, Invitrogen) supplemented with 10% FCS
(PAA Laboratories), and 2 mM glutamine at 37C/7% CO2. Two days
prior to infection, 2 3 106 Caco2 cells or 2 3 105 J774 cells were
seeded into 24-well plates. An overnight culture of Listeria was diluted
1:50 in BHI medium (Difco) and grown at 37C till the middle of the log
phase. Bacteria were washed twice in medium without FCS, and
8 3 106 (Caco2) or 2 3 105 (J774) bacteria were added to the mono-
layer (Caco2) or semiconfluent cells (J774)/well, centrifuged 5 min at
500 g, and incubated for 1 hr. Cells were washed with PBS. Medium
containing 100 mg/ml gentamicin was added to kill extracellular bacte-
ria. After 1, 2, 3, and 4 hr, cells were washed with PBS and lysed with
sterile water containing 0.2% Triton X-100. Serial dilutions of cell
lysates were plated onto BHI agar plates and incubated 24 hr at
37C. Colonies were counted, and the recovery per well was deter-
mined. Each data point of one experiment was determined three times,
and experiments were independently repeated in triplicate.
Adhesion assays were performed like invasion assays without
centrifugation after addition of bacteria to Caco2 cells. Thirty minutes
p.i., cells were washed 5-fold with PBS and lysed with 0.2% Triton
X-100. Bacterial numbers were determined as described.
Mouse Infection
Ten-weeks-old female C57BL/6J mice were purchased from Harlan-
Winkelmann (Borchen) and housed for a further week in the specific
pathogen-free (SPF) animal facility (Helmholtz Centre for Infection
Research) prior to infection. Lmo-EGD and Lmo-InlAm were grown
in brain-heart infusion (BHI) broth (BD-Difco) until the end of the
log-growth phase. After washing, bacteria were diluted in PBS. A
total of 0.2 ml of the desired inoculum of either strain was mixed
with 0.3 ml PBS containing 50 mg CaCO3 (Lecuit et al., 2001). The
suspension was inoculated intragastrically into mice (starved over-
night, water allowed) with a 21 gauge feeding needle attached to
a 1 ml syringe. Animals were then either monitored daily to determine
survival rates or they were sacrificed and dissected for histological
analysis or for determining bacterial counts in organs at the time
points indicated. All animal experiments were reviewed and approved
by local authorities. For infection of C57BL/6J mice intravenously,
Lmo-EGD or Lmo-InlAm were prepared as described (Pasche et al.,
2005). Survival rates and organ loads were determined as described
for oral infections.
Infection of Pregnant Mice
BALB/c mice (Harlan-Winkelmann) were infected intragastrically or
intravenously on day E13.5 or E14.5 as described above. Animals
were examined daily. At indicated time points p.i., micewere sacrificed
and the abdominal cavity was opened aseptically. Each placenta and
fetus was independently dissected and analyzed with cfu determina-
tion or histopathology.
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Bacterial Counts in Organs, Placentae, and Embryos
Stomach and small intestine were removed and incubated for 2 hr at
20C in PBS supplemented with 100 mg/ml gentamicin (Gibco) to kill
extracellular bacteria; other organs and embryos were sterilely dis-
sected. Organs and embryos were homogenized, and serial dilutions
were plated onto BHI agar, thus allowing a determination of bacterial
counts per mg organ/embryo.
Statistical Analysis
Survival curves were statistically evaluated by Kaplan-Meier and Log-
rank (Mantel-Cox) analyses. Bacterial loads are listed asmedian ±95%
confidence intervals, statistically evaluated by the Mann-Whitney U
nonparametic test. Calculations were done with GraphPadPrism4
(GraphPad Software). Differences were considered significant for
p% 0.05.
Histology and Immunohistochemistry
Organs were fixed in 10% formalin, dehydrated, and embedded in par-
affin. Sections of 5 mmwere cut and stained with hematoxylin-eosin or
used for immunohistochemistry (IHC). For detection of Lmo Listeria, O
antiserum (Serotype 1 and 4; BD-Difco) was used. For detection, a sec-
ondary, peroxidase-coupled goat-anti-rabbit antibody was used. IHC
sections were counterstained with hematoxylin.
Supplemental Data
Supplemental Data include six figures and one table and can be found
with this article online at http://www.cell.com/cgi/content/full/129/5/
891/DC1/.
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